Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
526
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.53M | 0.03% |
88,719
+1,811
| +2% | +$25.4K |
|
527
MetLife
MET
$61.1B
| $1.53M | 0.03% |
+30,104
| New | +$1.45M |
|
|
HI
528
DELISTED
Hillenbrand
HI
| $1.53M | 0.03% |
45,922
-4,958
| -10% | -$157K |
|
|
CLVS
529
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.53M | 0.03% |
+146,799
| New | +$1.07M |
|
530
Antero Resources
AR
$11.6B
| $1.53M | 0.03% |
535,993
-1,152,925
| -68% | -$2.94M |
|
531
Acuity Brands
AYI
$10.1B
| $1.53M | 0.03% |
11,068
+1,573
| +17% | +$202K |
|
532
World Kinect Corp
WKC
$1.82B
| $1.52M | 0.03% |
35,095
+109
| +0.3% | +$4.56K |
|
533
Progressive
PGR
$130B
| $1.52M | 0.03% |
20,983
-119
| -0.6% | -$8.58K |
|
534
Kaiser Aluminum
KALU
$2.49B
| $1.52M | 0.03% |
13,692
+10,339
| +308% | +$1.11M |
|
535
Axalta
AXTA
$7.72B
| $1.51M | 0.03% |
49,824
-25,240
| -34% | -$744K |
|
536
Innoviva
INVA
$1.52B
| $1.51M | 0.03% |
106,934
-54,142
| -34% | -$664K |
|
537
Affiliated Managers Group
AMG
$9.28B
| $1.5M | 0.03% |
17,668
-17,756
| -50% | -$1.46M |
|
538
Badger Meter
BMI
$3.94B
| $1.49M | 0.03% |
22,958
-5,284
| -19% | -$314K |
|
539
Aon
AON
$76.2B
| $1.49M | 0.03% |
7,141
-538
| -7% | -$107K |
|
|
VGR
540
DELISTED
Vector Group Ltd.
VGR
| $1.48M | 0.03% |
155,488
-44,776
| -22% | -$392K |
|
541
National Vision
EYE
$1.44B
| $1.47M | 0.03% |
+45,456
| New | +$1.25M |
|
|
UCTT
542
Ultra Clean Holdings
UCTT
$3.3B
| $1.47M | 0.03% |
+62,814
| New | +$1.27M |
|
543
Cheesecake Factory
CAKE
$5.7B
| $1.47M | 0.03% |
37,882
-70,678
| -65% | -$2.91M |
|
|
MGLN
544
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.46M | 0.03% |
18,589
+6,704
| +56% | +$471K |
|
|
AVB
545
DELISTED
AvalonBay Communities
AVB
| $1.45M | 0.03% |
6,935
+349
| +5% | +$74.8K |
|
546
Atkore
ATKR
$3.16B
| $1.45M | 0.03% |
35,843
+27,437
| +326% | +$1.02M |
|
547
TTM Technologies
TTMI
$11.3B
| $1.45M | 0.03% |
96,119
-98,373
| -51% | -$1.29M |
|
548
Azenta
AZTA
$1.44B
| $1.44M | 0.03% |
+34,368
| New | +$1.44M |
|
549
Jack in the Box
JACK
$342M
| $1.43M | 0.03% |
18,331
+8,908
| +95% | +$738K |
|
550
Winnebago Industries
WGO
$909M
| $1.42M | 0.03% |
26,764
+15,258
| +133% | +$713K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.